Scarica l'app Stockscreener
11.07
2.98%
0.32
Dopo l'orario di chiusura:
11.05
-0.02
-0.18%
Absci Corp Borsa (ABSI) Ultime notizie
Artificial Intelligence Stocks To Follow TodayOctober 1st - MarketBeat
Absci Corporation $ABSI Shares Newly Acquired by Bank of America Corp DE - MarketBeat
Guggenheim reiterates Absci stock rating on endometriosis trial delay - Investing.com
ABSCI Corp Agencies, 2024 - OpenSecrets
ABSI Stock Eyes Best Day Ever After Positive Hair Loss Drug Data, $100M Lilly-Backed Raise - Stocktwits
Absci (NASDAQ:ABSI) Given "Buy" Rating at Needham & Company LLC - MarketBeat
Absci Corporation (ABSI) Stock Price, News, Quote & History - Yahoo! Finance Canada
LifeSci Capital Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $16 - Moomoo
Absci Corporation Announces Preliminary Details for Phase 2 Storyline? Trial of Ai-Designed Antibody Abs-201? for Endometriosis - marketscreener.com
Absci plans phase 2 trial of ABS-201 for endometriosis in 2027 - Investing.com
Absci Expects to Initiate Mid-Stage Trial of ABS-201 for Endometriosis in Mid-2027 - Yahoo Finance
Absci Announces Preliminary Details for Phase 2 STORYLINE™ Trial of AI-Designed Antibody ABS-201™ for Endometriosis - The Manila Times
Absci Announces Preliminary Details for Phase 2 STORYLINE Trial of AI-Designed Antibody ABS-201 for Endometriosis - Moomoo
Absci (NASDAQ:ABSI) Stock Price Down 8.3%What's Next? - MarketBeat
Wall Street Analysts Predict a 28.3% Upside in ABSCI CORP (ABSI): Here's What You Should Know - Eastern Progress
Absci (ABSI) Stock Looks Expensive Against Its Book Value - Yahoo Finance
H.C. Wainwright Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $16 - Moomoo
Absci Corporation (ABSI) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Absci (NASDAQ:ABSI) Stock Price Up 12.5%Here's What Happened - MarketBeat
Artificial Intelligence Stocks Worth WatchingSeptember 17th - marketbeat.com
Absci at Morgan Stanley healthcare conference: AI platform meets clinical test - Investing.com
Squarepoint Ops LLC Sells 228,841 Shares of Absci Corporation $ABSI - MarketBeat
Baldness Drug Stocks like Veradermics (MANE) and Absci (ABSI) Are Chasing the Same Wall Street Magic as Ozempic - Yahoo Finance
Lifesci Capital Begins Coverage on Absci (NASDAQ:ABSI) - MarketBeat
LifeSci Capital Initiates Absci Corp(ABSI.US) With Buy Rating, Announces Target Price $16 - moomoo.com
Absci's Billion-Dollar Hair Bet: Why The AI Story Doesn't Add Up (NASDAQ:ABSI) - Seeking Alpha
BTIG Maintains Absci Corp(ABSI.US) With Buy Rating, Raises Target Price to $16 - moomoo.com
Absci Corporation Stock (ABSI) Opinions on Investor Conference Participation - Quiver Quantitative
Bank of New York Mellon Corp Buys Shares of 386,832 Absci Corporation $ABSI - MarketBeat
ABSI: Absci Corp Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Absci Corporation $ABSI Shares Bought by Bank of America Corp DE - MarketBeat
Absci (NASDAQ:ABSI) Stock Price Down 4.8%Should You Sell? - MarketBeat
Can Absci’s (ABSI) Low-Frequency Hair Loss Therapy Redefine Its Long-Term Platform Potential? - simplywall.st
Absci Corp CFO Zachariah Jonasson Reports RSU Tax Withholding Share Transaction - Kalkine Media
Absci to Participate in Upcoming Investor Conferences - The Manila Times
Deutsche Bank AG Acquires New Stake in Absci Corporation $ABSI - MarketBeat
Forget GLP-1 stocks, baldness drugs are Wall Street’s next goldmine - Fortune
Artia Global Partners LP Acquires Shares of 464,444 Absci Corporation $ABSI - marketbeat.com
Absci (NASDAQ:ABSI) Trading 8.5% HigherWhat's Next? - MarketBeat
Certain Common Stock of Absci Corporation are subject to a Lock-Up Agreement Ending on 24-AUG-2026. - marketscreener.com
Absci (NASDAQ:ABSI) Shares Gap UpShould You Buy? - MarketBeat
Morgan Stanley Maintains Absci Corp(ABSI.US) With Hold Rating, Raises Target Price to $10 - 富途牛牛
Absci (ABSI) Q2 2026 Earnings Call Transcript - AOL.com
Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does. - GlobeNewswire
Ransi Mudalinayake Somaratne Net Worth (2026) - GuruFocus
The Zacks Analyst Blog Highlights Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci - Zacks Investment Research
4 AI-Powered Drug Discovery Stocks to Watch as AI Reshapes Pharma - The Globe and Mail
ABSI Looks 1092.2% Overvalued on GF Value™ - GuruFocus
Absci Corp (ABSI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Absci Corporation (NASDAQ:ABSI) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Absci (NASDAQ:ABSI) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Absci (NASDAQ:ABSI) Trading Down 4.4%Here's Why - MarketBeat
Will Absci (NASDAQ:ABSI) Spend Its Cash Wisely? - Moomoo
0.05%
0.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):